About ProcartaPlex strengths for Luminex platform
About ProcartaPlex strengths for Luminex platform
- It is not combinable with simplexes or other panels.
- ProcartaPlex preconfigured panels are widely tested for combinationability, interference and cross-reactivity of analytes to provide the highest level of validation and accuracy
- Panels are available in several formats for six species (human, mouse, rat, non-human primate, pig and dog)
- Provide with the reagents necessary to perform the dosing
- Target list [microbead region]:EpCAM [25], glypican-1 (GPC1) [34], HSP27 [36], HSP60 [13], IGF-2 [12], Midkine (MK) [28], SPARC (osteonectin) [67], TRKB [61]
- ProcartaPlex immunoassays are based on the principles of a sandwich ELISA
- They use two highly specific antibodies binding to different epitopes of a protein to simultaneously quantify all protein targets using a Luminex instrument
- ProcartaPlex multiplex assays require up to 25 μl of plasma or serum, or 50 μl of cell culture supernatant
- The results analysed can be obtained in just four hours
- Validated as the most demanding panel on the market, including the combination of protein targets and cross-reactivity tests
- Luminex technology is the most referenced multixing platform for protein detection and quantitative analysis
The panel allows you to facilitate research on the...
The panel facilitates cancer research by analyzing eight protein targets involved in cell proliferation using Luminex xMAP technology.
Allows simultaneous detection of protein...
Allows simultaneous detection of soluble proteins, which are key regulators of cell proliferation and are involved in sustained proliferative signaling and cell growth
Uncontrolled expression of signals of...
Uncontrolled expression of proliferation and survival signals allows cancer cells to grow continuously, thus paving the way for invasion and metastasis
Provided in a ready-to-use format with...
Provided in a ready-to-use format with individual vials of capture and detection reagents formulated at a concentration of 1X.
This format requires less pipeting and less...
This format requires less pipeting and experimental configuration
Technical specifications
| General |
| Brand | Invitrogen |
| Supplier ref. (Fisher Scientific) | 17480743 |
| Specifications |
| Product type | Multiplex panel |
| Quantity | 96 dosages |
| Species | Human |
| Combinability | Not combinable |
| Sensitivity of the dosage | See Certificate of Analysis |
| Dose range | See Certificate of Analysis |
| Format | Multiplex kit |
| For use with (equipment) | Luminex™ Instruments |
| Coefficient of inter-dose variation | Less than 15 % |
| Coefficient of intra-dose variation | Less than 15 % |
| Product range | ProcartaPlex™ |
| Type of sample | Serum, plasma, cell culture supernatants, Plasma, Cell Culture Supernatants |
| dimResearchArea | Immunology, Oncology |
| Physical characteristics |
| Multiplex, size Plex n° | 8 |
| Volume of sample | Serum, plasma: 25 µl, cell culture supernatant: 50 µl |
| Storage and shipping |
| Content and storage | • 2 vials of human standard 9 mixture (lyophilized) • 1 vial of capture microbeads (1X) • 1 bottle of biotinylated antibody mixture (1X) • 1 vial of reading pad (1X) • 1 vial of Streptavidine-PE (1X) • 1 vial of universal dosing buffer (1X |
Origin and customs
| Manufacturer ref. | EPX080-15844-901 |
|---|
| Country of origin | Autriche |
|---|
| HS customs code | 3002 15 00 00 |
|---|
A question or a specific configuration?
Contact us for a quote.